Nemean Asset Management, LLC 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-09-21 1:31 pm Sale | 2021-09-07 | 13G | Forte Biosciences, Inc. FBRX | Nemean Asset Management, LLC | 0 0.000% | -26,043 (Position Closed) | Filing |
| 2021-02-16 3:20 pm Purchase | 2020-12-31 | 13G | Forte Biosciences, Inc. FBRX | Nemean Asset Management, LLC | 26,043 5.100% | 3,600 (+16.04%) | Filing |
| 2020-09-01 09:10 am Purchase | 2020-08-28 | 13G | Forte Biosciences, Inc. FBRX | Nemean Asset Management, LLC | 22,443 5.010% | 22,443 (New Position) | Filing |